TAK1-IN-2 is a potent and selective TAK1 inhibitor, with an IC 50>: of 2 nM.Appearance:SolidIC50&: Target:TAK1 2 nM (IC 50 )In Vitro:TAK1-IN-2 (compound 54) (10 μM) has no effect on cell viability in TNF-α stimulated HCT-15 cells. MCE has not
TAK1-IN-2 is a potent and selective TAK1 inhibitor, with an IC 50>: of 2 nM.Appearance:SolidIC50&: Target:TAK1 2 nM (IC 50 )In Vitro:TAK1-IN-2 (compound 54) (10 μM) has no effect on cell viability in TNF-α stimulated HCT-15 cells. MCE has not
TAK1-IN-2 is a potent and selective TAK1 inhibitor, with an IC 50>: of 2 nM.Appearance:SolidIC50&: Target:TAK1 2 nM (IC 50 )In Vitro:TAK1-IN-2 (compound 54) (10 μM) has no effect on cell viability in TNF-α stimulated HCT-15 cells. MCE has not
TAK1-IN-2 is a potent and selective TAK1 inhibitor, with an IC 50>: of 2 nM.Appearance:SolidIC50&: Target:TAK1 2 nM (IC 50 )In Vitro:TAK1-IN-2 (compound 54) (10 μM) has no effect on cell viability in TNF-α stimulated HCT-15 cells. MCE has not
TAK1-IN-2 is a potent and selective TAK1 inhibitor, with an IC 50>: of 2 nM.Appearance:SolidIC50&: Target:TAK1 2 nM (IC 50 )In Vitro:TAK1-IN-2 (compound 54) (10 μM) has no effect on cell viability in TNF-α stimulated HCT-15 cells. MCE has not
TAK1-IN-2 is a potent and selective TAK1 inhibitor, with an IC 50>: of 2 nM.Appearance:SolidIC50&: Target:TAK1 2 nM (IC 50 )In Vitro:TAK1-IN-2 (compound 54) (10 μM) has no effect on cell viability in TNF-α stimulated HCT-15 cells. MCE has not
TAK1-IN-2 is a potent and selective TAK1 inhibitor, with an IC 50>: of 2 nM.Appearance:SolidIC50&: Target:TAK1 2 nM (IC 50 )In Vitro:TAK1-IN-2 (compound 54) (10 μM) has no effect on cell viability in TNF-α stimulated HCT-15 cells. MCE has not
TAK1-IN-2 is a potent and selective TAK1 inhibitor, with an IC 50>: of 2 nM.Appearance:SolidIC50&: Target:TAK1 2 nM (IC 50 )In Vitro:TAK1-IN-2 (compound 54) (10 μM) has no effect on cell viability in TNF-α stimulated HCT-15 cells. MCE has not
ROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC 50 of <:1 μM.In VitroRho-associated protein kinase (ROCK) is a member of the serine-threonine protein kinase family. ROCK, which exists in
ROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC 50 of <:1 μM.In VitroRho-associated protein kinase (ROCK) is a member of the serine-threonine protein kinase family. ROCK, which exists in
ROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC 50 of <:1 μM.In VitroRho-associated protein kinase (ROCK) is a member of the serine-threonine protein kinase family. ROCK, which exists in
ROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC 50 of <:1 μM.In VitroRho-associated protein kinase (ROCK) is a member of the serine-threonine protein kinase family. ROCK, which exists in
ROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC 50 of <:1 μM.In VitroRho-associated protein kinase (ROCK) is a member of the serine-threonine protein kinase family. ROCK, which exists in
ROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC 50 of <:1 μM.In VitroRho-associated protein kinase (ROCK) is a member of the serine-threonine protein kinase family. ROCK, which exists in
ROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC 50 of <:1 μM.In VitroRho-associated protein kinase (ROCK) is a member of the serine-threonine protein kinase family. ROCK, which exists in
ROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC 50 of <:1 μM.In VitroRho-associated protein kinase (ROCK) is a member of the serine-threonine protein kinase family. ROCK, which exists in
ROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC 50 of <:1 μM.In VitroRho-associated protein kinase (ROCK) is a member of the serine-threonine protein kinase family. ROCK, which exists in
ROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC 50 of <:1 μM.In VitroRho-associated protein kinase (ROCK) is a member of the serine-threonine protein kinase family. ROCK, which exists in